The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

Boston Scientific Corporation ( NYSE: BSX) TD Cowen 45th Annual Healthcare Conference March 4, 2025 9:10 AM ET Dan Brennan - Chief Financial Officer Ken Stein - Chief Medical Officer Art Butcher - ...

When we think of ways to protect our hearts, diet and exercise often come to mind first. But while doing enough cardio and ...

J&J's Varipulse PFA catheter recall investigation found the number of ablations, stacked ablations and ablation location may ...

Discover how hypertension, diabetes, atrial fibrillation, high cholesterol, and obesity increase stroke risk, and learn ...

AFib is more common in people who are older than 65. It’s also more common in men than women. Underlying heart disease, high blood pressure, thyroid problems, excessive alcohol use, sleep apnea, and ...

Our easy-to-read patient fact sheet compares and contrasts sinus arrhythmia vs AFib (atrial fibrillation) symptoms.

Atrial Fibrillation (AF) is a heart condition that causes an irregular and often fast heartbeat. It affects many people and ...

Google's Pixel phone gains FDA clearance for pulse loss detection. The feature monitors heart rhythms and alerts users to ...

Mike Gomez, a resident of Austin, Texas, recently shared how his Apple Watch helped save his life after the device alerted him to possible heart issues via a series of irregular heart rate ...

Oral anticoagulation is the most effective intervention for the prevention of ischaemic stroke in people with atrial ...

Heart Month may be coming to a close, but Apple Watch continues to save lives. The latest story comes out of Austin, Texas. Mike Gomez credits the Apple Watch with helping to save his life after ...